SILBER ALLAN C

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 36% 68% 82%
Transactions
4 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
SILBER ALLAN C's trades of POINT Biopharma Global Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
494.10
Quantity 13,817 -28.1%
Value US$81,554
Transaction date
Sale
Price
84.51
Quantity 88,213 -34.7%
Value US$3,161,366
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-21 2022-11-18
B Purchase
95,292 +48.3%
241.00
US$4,681,791 		95,292 +48.3% 241.00 US$4,681,791
2022-11-21 2022-11-17
B Purchase
13,817 -28.1%
494.10
US$81,554 		13,817 -28.1% 494.10 US$81,554
2021-08-20 2021-08-19
S Sale
88,213 -34.7%
84.51
US$3,161,366 		88,213 -34.7% 84.51 US$3,161,366
2021-08-17 2021-08-13
S Sale
2,500 -0.1%
1.90
US$4,750 		2,500 -0.1% 1.90 US$4,750